JPRN-UMIN000001014已完成1 期
Phase I clinical study of peptide vaccine using novel tumor-associated antigen TTK against advanced esophageal carcinoma - TTK peptide vaccine to advanced esophageal cancer
niversity of Tokyo0 个研究点目标入组 6 人开始时间: 2008年2月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy Uncontrolled infection Uncontrolled brain metastasis
研究者
相似试验
已完成
1 期
PhaseI/II clinical study of peptide vaccine against advanced or recurrent gastric cancerAdvanced or recurrent gastric cancer refractory to standard therapeutic modalityJPRN-UMIN000004389Department of Gastroenterological Surgery,Graduate School of Medicine,Osaka University30
已完成
2 期
Phase II clinical trial of peptide vaccination with HLA-A2402-restricted KIF20A and VEGFR1 epitope peptides with gemcitabine chemotherapy in patients with unresectable advanced pancreatic cancerpancreatic cancerJPRN-UMIN000004641Department of Gastroenterology Juntendo University School of Medicine40
已完成
不适用
Phase I clinical trial of peptide vaccine with UFT/LV for advanced or recurrent colorectal canceradvanced or recurrent colorectal cancerJPRN-UMIN000004452Tokyo Women's Medical University10
已完成
1 期
Phase I study of peptide-cocktail vaccination for HCV-positive patients with liver cancer who have undergone radical therapy.liver cancerJPRN-UMIN000003773Kurume University Cancer Vaccine Center3
已完成
1 期
Phase I study of peptide vaccination for patients with unresectable biliary tract cancerbiliary tract cancerJPRN-UMIN000003229Tokyo Women's Medical University9